Cite
HARVARD Citation
Ling, L. et al. (2016). Nebivolol as a first-line antihypertensive: a justifiable proposal?. Heart Asia. 8 (1), pp. 28-29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ling, L. et al. (2016). Nebivolol as a first-line antihypertensive: a justifiable proposal?. Heart Asia. 8 (1), pp. 28-29. [Online].